exact sciences is a molecular diagnostics company focused on colorectal cancer. the company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. stool-based dna (sdna) technology is included in the colorectal cancer screening guidelines of the american cancer society and the u.s. multi-society task force on colorectal cancer. for more information on exact sciences' noninvasive colon cancer screening test, visit cologuardtest.com
Company profile
Ticker
EXAS
Exchange
Website
CEO
Kevin Conroy
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
EXACT CORP
SEC CIK
Corporate docs
Subsidiaries
Genomic Health, Inc. • Exact Sciences Laboratories, LLC • Exact Sciences Thrive, LLC ...
IRS number
204782291
EXAS stock data
Latest filings (excl ownership)
8-K
Other Events
8 May 24
424B7
Prospectus with selling stockholder info
8 May 24
10-Q
2024 Q1
Quarterly report
8 May 24
8-K
Exact Sciences Announces First-Quarter 2024 Results
8 May 24
8-K
Departure of Directors or Certain Officers
25 Apr 24
ARS
2023 FY
Annual report to shareholders
25 Apr 24
DEFA14A
Additional proxy soliciting materials
25 Apr 24
DEF 14A
Definitive proxy
25 Apr 24
8-K
Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes
17 Apr 24
8-K
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
15 Apr 24
Transcripts
EXAS
Earnings call transcript
2024 Q1
8 May 24
EXAS
Earnings call transcript
2023 Q4
21 Feb 24
EXAS
Earnings call transcript
2023 Q3
1 Nov 23
EXAS
Earnings call transcript
2023 Q2
1 Aug 23
EXAS
Earnings call transcript
2023 Q2
1 Aug 23
EXAS
Earnings call transcript
2023 Q1
9 May 23
EXAS
Earnings call transcript
2022 Q4
21 Feb 23
EXAS
Earnings call transcript
2022 Q3
4 Nov 22
EXAS
Earnings call transcript
2022 Q2
2 Aug 22
EXAS
Earnings call transcript
2022 Q1
27 Apr 22
Latest ownership filings
4
D SCOTT COWARD
2 May 24
4
Everett Cunningham
2 May 24
4
James Herriott
2 May 24
4
Jeffrey Thomas Elliott
2 May 24
4
Brian Baranick
2 May 24
4
Sarah Condella
2 May 24
4
JACOB A ORVILLE
2 May 24
4
Kevin T Conroy
2 May 24
144
Notice of proposed sale of securities
1 May 24
144
Notice of proposed sale of securities
1 May 24
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 351.78 mm | 351.78 mm | 351.78 mm | 351.78 mm | 351.78 mm | 351.78 mm |
Cash burn (monthly) | 85.96 mm | 5.82 mm | 36.14 mm | 20.78 mm | 27.44 mm | (no burn) |
Cash used (since last report) | 136.73 mm | 9.26 mm | 57.49 mm | 33.05 mm | 43.64 mm | n/a |
Cash remaining | 215.05 mm | 342.52 mm | 294.30 mm | 318.73 mm | 308.14 mm | n/a |
Runway (months of cash) | 2.5 | 58.8 | 8.1 | 15.3 | 11.2 | n/a |
Institutional ownership, Q4 2023
20.1% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 4 |
Opened positions | 0 |
Closed positions | 602 |
Increased positions | 1 |
Reduced positions | 3 |
13F shares | Current |
---|---|
Total value | 2.07 bn |
Total shares | 37.17 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
JPM JPMorgan Chase & Co. | 17.34 mm | $1.28 bn |
Wellington Management | 10.54 mm | $779.51 mm |
Lord, Abbett & Co. | 9.26 mm | $8.66 mm |
Loomis Sayles & Co L P | 30.25 k | $2.24 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 May 24 | Brian Baranick | Common Stock | Sell | Dispose S | No | Yes | 60.15 | 110 | 6.62 k | 13,279 |
1 May 24 | Sarah Condella | Common Stock | Sell | Dispose S | No | Yes | 60.15 | 102 | 6.14 k | 72,611 |
1 May 24 | Jacob A Orville | Common Stock | Sell | Dispose S | No | Yes | 60.15 | 102 | 6.14 k | 14,440 |
1 May 24 | Everett Cunningham | Common Stock | Sell | Dispose S | No | Yes | 60.15 | 136 | 8.18 k | 47,042 |
1 May 24 | D Scott Coward | Common Stock | Sell | Dispose S | No | Yes | 60.15 | 67 | 4.03 k | 44,644 |
30 Apr 24 | Brian Baranick | Common Stock | Grant | Acquire A | No | No | 0 | 218 | 0.00 | 13,389 |
30 Apr 24 | Sarah Condella | Common Stock | Grant | Acquire A | No | No | 30.02 | 708 | 21.25 k | 72,713 |
30 Apr 24 | Sarah Condella | Common Stock | Grant | Acquire A | No | No | 0 | 218 | 0.00 | 72,005 |
30 Apr 24 | Jacob A Orville | Common Stock | Grant | Acquire A | No | No | 0 | 218 | 0.00 | 14,542 |
30 Apr 24 | Everett Cunningham | Common Stock | Grant | Acquire A | No | No | 30.02 | 708 | 21.25 k | 47,178 |
News
BTIG Maintains Buy on Exact Sciences, Lowers Price Target to $80
9 May 24
Canaccord Genuity Maintains Buy on Exact Sciences, Lowers Price Target to $85
9 May 24
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
9 May 24
Citigroup Maintains Buy on Exact Sciences, Lowers Price Target to $80
9 May 24
Stocks Rebound As Rising Jobless Claims Sustain Rate-Cut Hopes, Dollar Falls, Gold Rallies: What's Driving Markets Thursday?
9 May 24
Press releases
Exact Sciences Announces First-Quarter 2024 Results
8 May 24
Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024
7 May 24
Exact Sciences to Participate in May Investor Conference
1 May 24
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
15 Apr 24
Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes
11 Apr 24